AP NEWS

Global Adult Malignant Glioma Ongoing Clinical Trials - Analysis & Outlook to 2022 - ResearchAndMarkets.com

August 1, 2018

DUBLIN--(BUSINESS WIRE)--Aug 1, 2018--The “Adult Malignant Glioma Ongoing Global Clinical Trials Analysis and Outlook” report has been added to ResearchAndMarkets.com’s offering.

Adult Malignant Glioma ongoing clinical trials report provides comprehensive analysis and trends in global Adult Malignant Glioma disease clinical trials. The research work analyzes the ongoing Adult Malignant Glioma clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Adult Malignant Glioma treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Adult Malignant Glioma clinical trials.

Scope of the Report:

Ongoing Adult Malignant Glioma clinical trials across regions Trial information by Phase and Subjects recruited Trial information by status, type, sponsor type Drugs used for treatment of Adult Malignant Glioma Both observational and interventional trials analyzed Leading companies and universities participating in Adult Malignant Glioma clinical trials

Reasons to Buy:

Track competition and design competitive advantages Identify right partners to associate with for further research Evaluate potential opportunities available in further clinical trials of the disease Formulate business development strategies through success rates of clinical trials Identify quick markets for recruiting subjects based on trials count by each market

Key Topics Covered:

1. Table of Contents

2. Key Findings, 2018

3. Clinical Trials Trends to 2022

4. Country Level Analysis

5. Company Level Analysis

6. Enrolment Trends to 2022

7. Ongoing Trials- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company Details

8. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/sg77st/global_adult?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180801005390/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Clinical Trials

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL OTHER SCIENCE SCIENCE GENERAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/01/2018 05:32 AM/DISC: 08/01/2018 05:32 AM

http://www.businesswire.com/news/home/20180801005390/en

AP RADIO
Update hourly